number of access : ?
number of downloads : ?
ID 116097
Author
Hayashi, K Hayashi Hospital
Yasuoka, T Hayashi Hospital
Bando, Hiroshi Hayashi Hospital|Tokushima University|Japan Low Carbohydrate Diet Promotion Association KAKEN Search Researchers
Miki, K Hayashi Hospital
Nakagawa, M Hayashi Hospital
Zushi, T Hayashi Hospital
Suzuki, C Hayashi Hospital
Shibata, R Hayashi Hospital
Takata, T Hayashi Hospital
Sato, M Hayashi Hospital
Keywords
Multiple daily insulin injection (MDI)
Xultophy
Type 2 Diabetes Mellitus (T2DM)
Bio-psycho-social
Glucagon like peptide-1 receptor agonist (GLP-1RA)
Content Type
Journal Article
Description
The case was 79-year-old female with type 2 diabetes mellitus (T2DM) and other medical problems who has been treated on insulin for Multiple Daily Injections (MDI). She has recently developed cough and was diagnosed as slight bronchopneumonia, followed by the admission to the hospital with intensive treatment. Simultaneously, she could not control her usual daily life, and then her diabetic therapy was changed to Xultophy. It is the combined agent of liraglutide and insulin degludec that can be injected once a day. In this article, the clinical progress and some discussion from various points of view would be described.
Journal Title
SunText Review of Medical & Clinical Research
ISSN
27664813
Publisher
SunText Reviews
Volume
2
Issue
2
Start Page
126
Published Date
2021-04-17
Rights
This is an open-access article distributed under the terms of the Creative Commons Attribution License(https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
DOI (Published Version)
FullText File
language
eng
TextVersion
Publisher
departments
Medical Sciences